title: [Psychological aspects of immunotherapies in the treatment of malignant melanoma].
abstract: Psychological problems may arise in connection with oncomedical treatments in three ways: 1. acute and/or 2. chronic ways, as well as 3. co-morbid psychiatric diseases that already exist must also be taken into account. Immunotherapies have the most common and also clinically relevant psychological side effects. Fatigue, anhedonia, social isolation, psychomotor slowness is reported during treatment. Anti-CTLA-4 antibody (ipilimumab) immunotherapy can present one of the most modern opportunities for adequate treatment for patients having distant metastasis or unresectable tumour. In relation to immunotherapies, acute psychological side effects (acute stress) emerging during treatments develop in a way that can mostly be linked to environmental factors, e.g. notification of diagnosis, hospitalisation, progression, deterioration in quality of life, imminent dates of control. Crisis is a temporary and threatening condition that endangers psychological balance. In such conditions, enhanced psychological vulnerability must be taken into account and doctors play a key role in the rapid recognition of the condition. Chronic psychological problems, which may arise from the depressogenic effect of the applied treatment or originated from a pre-melanoma psychiatric condition, may exceed the diagnostic and psychotherapeutic competences of a clinical psychologist. Even in case of a well-defined depressogenic biological mechanism such as the activation of the pro-inflammatory cytokine pathway, positive environmental effects can reduce symptoms and thus increase compliance. Side effects can be treated successfully using psychotherapeutic methods and/or psychiatric medicines. The application of routinely used complex psychosocial screening packages can provide the easiest method to identify worsening psychological condition during immunotherapy and give rapid feedback to the oncologist and the patient. Team work is of particular importance in a situation like this as it requires complex, interdisciplinary and high-level professional collaboration. Multidisciplinarity is the basic framework for modern tumour therapy where, under the guidance of oncologists, the work of specialist nurses, social workers, physiotherapists, dieticians and last but not least psychiatrists/psychologists are indispensable and play a significant role.
authors.affiliation: Mentális Egészségtudományok Doktori Iskola, Semmelweis Egyetem, Budapest, Hungary.
authors.forename: Péter
authors.initials: P
authors.lastname: Kovács
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Gitta
authors.initials: G
authors.lastname: Pánczél
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Krisztina
authors.initials: K
authors.lastname: Melegh
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Tímea
authors.initials: T
authors.lastname: Balatoni
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Edit
authors.initials: E
authors.lastname: Pörneczy
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Lenke
authors.initials: L
authors.lastname: Lõrincz
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Kata
authors.initials: K
authors.lastname: Czirbesz
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Eszter
authors.initials: E
authors.lastname: Gorka
authors.affiliation: Bõrgyógyászati Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kovacs.peter@oncol.hu.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Liszkay
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000523:psychology*; D008545:Melanoma / Q000628:therapy*; D011788:Quality of Life; D012878:Skin Neoplasms / Q000628:therapy*